23 results
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... respiratory distress syndrome ... #Pharmacology # ... Management #Treatment ... #Indications
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Failure, Toxins/Medications ... Abdominal compartment syndrome ... ) UOP > 0.5 cc/kg ... Differential #Diagnosis #criticalcare ... #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
amphotericin B, 3 to 5 mg/kg ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Checklist for Treatment of Delirium in the ICU 

Remove causative factors 
 - 
Exclude hypoglycemia if
Checklist for Treatment ... - Review the medication ... sleeping, administer pharmacologic ... Delirium #Checklist #Management ... #CriticalCare
Complex Regional Pain Syndrome (CRPS) - Treatment
Non-Pharmacologic:
 • Education
 • Physical & occupational therapy
 • Psychology
Regional Pain Syndrome ... (CRPS) - Treatment ... Non-Pharmacologic ... behavioral therapy) Medications ... #Treatment #Management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Disease Note: Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Cytokine Activation Syndrome ... Tocilizumab 4-8mg/kg ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
other factors (e.g ... ., concomitant medications ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
on MRA/CTA • Anterior ... Diagnosis: • Infection ... Electrolyte abnormality, Medication ... epilepticus Treatment ... #diagnosis #management